Cure My Disease

Don't miss your cure!

 Log in / Sign up

Vitamin d boost may enhance physical therapy for back pain

NCT ID NCT07439874

Symptom relief Sponsor: University of Tabuk Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether adding vitamin D supplements to physical therapy helps people with long-term low back pain. 200 adults from Saudi Arabia took part, with some getting physical therapy alone and others getting physical therapy plus vitamin D for six weeks. Researchers measured pain, disability, and blood markers to see if the combination worked better.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

200 people

The number who actually took part.

Started

Aug 2024

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 70 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * The study involves participants with LBP for more than 3 months. * Both genders, aged 20 to 70 years * Pain intensity of 4 or greater on the Numeric Pain Rating Scale * Capable of understanding and following instructions. Exclusion Criteria: * Skeletal deformities * Rheumatologic conditions * Progressive motor weakness * Incontinence * A history of cancer Use of systemic medications and illnesses Fractures.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Genetic alteration are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Congenital Abnormalities Low Back Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Genetic alteration Low back pain Physiotherapy

Contacts and locations

Locations

  • University of Tabuk

    Tabuk, Tabuk Region, 71491, Saudi Arabia

More trials for these conditions

Other studies related to the condition(s) this trial covers.